Dafna-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ASND",
  "EWTX",
  "ALKS",
  "RVMD",
  "ORIC",
  "GLPG",
  "BCAX",
  "BCYC",
  "ATXS",
  "ALLO",
  "RCUS",
  "GPCR",
  "IMTX",
  "TSHA",
  "ACET",
  "STOK",
  "LRMR",
  "MLYS",
  "ADCT",
  "SNDX",
  "KROS",
  "NGNE",
  "SAGE",
  "TSVT",
  "ALEC",
  "APRE",
  "BWAY",
  "PHGE",
  "AUTL",
  "NBIX",
  "KRRO",
  "KALV",
  "LXEO",
  "LCTX",
  "MDWD",
  null,
  "PVLA",
  "PRQR",
  "SPRO",
  "TELA",
  "STXS",
  "TNYA",
  "STRO",
  null,
  "IFRX",
  "PODD",
  "IDYA",
  null,
  "SPRY",
  null,
  "ATRC",
  "AQST",
  "RGLS",
  "ARAY",
  "GOSS",
  "ALGN",
  "CGEN",
  "CMPS",
  "ERAS",
  "ITOS",
  "INGN",
  "KURA",
  "URGN",
  "VKTX",
  "VYNE",
  "XENE",
  "FHTX",
  "BHVN",
  "TNDM",
  "IMVT",
  null,
  "AXGN",
  "BDTX",
  "BCRX",
  "BNTX",
  "BPMC",
  "CRDF",
  "IPSC",
  "DAWN",
  "CYTK",
  "DNLI",
  "DXCM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 83
Total Value: 352661806
Accession Number: 0001389933-25-000002
Form Type: 13F-HR
CIK: dafna-capital-management
Manager Name: Dafna-Capital-Management

Data Enrichment

94% identified

78 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

83 positions • $352.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 5

Sort by:

Arcus Biosciences, Inc.

RCUS|03969F109

Shares:625.1K

Value:$4.9M

% of Portfolio:1.4% ($4.9M/$352.7M)

04351PAD3

Shares:—

Value:$4.7M

% of Portfolio:1.3% ($4.7M/$352.7M)

DEXCOM INC

DXCM|252131107

Shares:65.6K

Value:$4.5M

% of Portfolio:1.3% ($4.5M/$352.7M)

BIOCRYST PHARMACEUTICALS INC

BCRX|09058V103

Shares:558.3K

Value:$4.2M

% of Portfolio:1.2% ($4.2M/$352.7M)

Edgewise Therapeutics, Inc.

EWTX|28036F105

Shares:183.1K

Value:$4.0M

% of Portfolio:1.1% ($4.0M/$352.7M)

GALAPAGOS NV

GLPG|36315X101

Shares:130.2K

Value:$3.3M

% of Portfolio:0.9% ($3.3M/$352.7M)

Inogen Inc

INGN|45780L104

Shares:458.1K

Value:$3.3M

% of Portfolio:0.9% ($3.3M/$352.7M)

INSULET CORP

PODD|45784P101

Shares:11.9K

Value:$3.1M

% of Portfolio:0.9% ($3.1M/$352.7M)

Alkermes plc.

ALKS|G01767105

Shares:94.2K

Value:$3.1M

% of Portfolio:0.9% ($3.1M/$352.7M)

Kura Oncology, Inc.

KURA|50127T109

Shares:463.4K

Value:$3.1M

% of Portfolio:0.9% ($3.1M/$352.7M)

Stoke Therapeutics, Inc.

STOK|86150R107

Shares:444.0K

Value:$3.0M

% of Portfolio:0.8% ($3.0M/$352.7M)

Immunovant, Inc.

IMVT|45258J102

Shares:170.0K

Value:$2.9M

% of Portfolio:0.8% ($2.9M/$352.7M)

Bicara Therapeutics Inc.

BCAX|055477103

Shares:212.0K

Value:$2.8M

% of Portfolio:0.8% ($2.8M/$352.7M)

ACCURAY INC

ARAY|004397105

Shares:1.2M

Value:$2.2M

% of Portfolio:0.6% ($2.2M/$352.7M)

2seventy bio, Inc.

TSVT|901384107

Shares:429.3K

Value:$2.1M

% of Portfolio:0.6% ($2.1M/$352.7M)

ProQR Therapeutics N.V.

PRQR|N71542109

Shares:1.6M

Value:$2.1M

% of Portfolio:0.6% ($2.1M/$352.7M)

COMPASS Pathways plc

CMPS|20451W101

Shares:711.0K

Value:$2.0M

% of Portfolio:0.6% ($2.0M/$352.7M)

Allogene Therapeutics, Inc.

ALLO|019770106

Shares:1.4M

Value:$2.0M

% of Portfolio:0.6% ($2.0M/$352.7M)

TELA Bio, Inc.

TELA|872381108

Shares:1.4M

Value:$1.8M

% of Portfolio:0.5% ($1.8M/$352.7M)

ALIGN TECHNOLOGY INC

ALGN|016255101

Shares:11.0K

Value:$1.7M

% of Portfolio:0.5% ($1.7M/$352.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Arcus Biosciences, Inc.(RCUScusip03969F109)	625.1K	QoQ +145.90% (+370.9K) YoY +169.77% (+393.4K)	All Managers (Combined)	$4.9M	1.4% ($4.9M/$352.7M)	QoQ +29.63% (+$1.1M) YoY +12.17% (+$532.4K)
(cusip04351PAD3)✕	—	QoQ - YoY -	All Managers (Combined)	$4.7M	1.3% ($4.7M/$352.7M)	QoQ +6.74% (+$297.5K) YoY +2.16% (+$100.0K)
DEXCOM INC(DXCMcusip252131107)	65.6K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.5M	1.3% ($4.5M/$352.7M)	QoQ -12.18% (-$621.4K) YoY -50.76% (-$4.6M)
BIOCRYST PHARMACEUTICALS INC(BCRXcusip09058V103)	558.3K	QoQ -16.30% (-108.7K) YoY -21.31% (-151.2K)	All Managers (Combined)	$4.2M	1.2% ($4.2M/$352.7M)	QoQ -16.52% (-$828.9K) YoY +16.16% (-$582.7K)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	183.1K	QoQ -2.13% (-4.0K) YoY -40.18% (-123.1K)	All Managers (Combined)	$4.0M	1.1% ($4.0M/$352.7M)	QoQ -19.36% (-$967.6K) YoY -27.85% (-$1.6M)
GALAPAGOS NV(GLPGcusip36315X101)	130.2K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.3M	0.9% ($3.3M/$352.7M)	QoQ -8.65% (-$309.8K) YoY -21.98% (-$921.6K)
Inogen Inc(INGNcusip45780L104)	458.1K	QoQ +119.39% (+249.3K) YoY +119.39% (+249.3K)	All Managers (Combined)	$3.3M	0.9% ($3.3M/$352.7M)	QoQ +70.58% (+$1.4M) YoY +93.83% (+$1.6M)
INSULET CORP(PODDcusip45784P101)	11.9K	QoQ -4.03% (-500) YoY -25.15% (-4.0K)	All Managers (Combined)	$3.1M	0.9% ($3.1M/$352.7M)	QoQ -3.46% (-$112.2K) YoY +14.67% (-$399.8K)
Alkermes plc.(ALKScusipG01767105)	94.2K	QoQ -21.95% (-26.5K) YoY NEW(+94.2K)	All Managers (Combined)	$3.1M	0.9% ($3.1M/$352.7M)	QoQ -10.39% (-$360.8K) YoY NEW(+$3.1M)
Kura Oncology, Inc.(KURAcusip50127T109)	463.4K	QoQ +3.34% (-15.0K) YoY +12.28% (-50.7K)	All Managers (Combined)	$3.1M	0.9% ($3.1M/$352.7M)	QoQ -21.68% (-$847.1K) YoY -65.25% (-$5.7M)
Stoke Therapeutics, Inc.(STOKcusip86150R107)	444.0K	QoQ +159.50% (+272.9K) YoY +206.20% (+299.0K)	All Managers (Combined)	$3.0M	0.8% ($3.0M/$352.7M)	QoQ +56.45% (+$1.1M) YoY +50.83% (+$995.1K)
Immunovant, Inc.(IMVTcusip45258J102)	170.0K	QoQ +57.40% (+62.0K) YoY +477.90% (+140.6K)	All Managers (Combined)	$2.9M	0.8% ($2.9M/$352.7M)	QoQ +8.60% (+$230.2K) YoY +205.67% (+$2.0M)
Bicara Therapeutics Inc.(BCAXcusip055477103)	212.0K	QoQ +100.94% (+106.5K) YoY NEW(+212.0K)	All Managers (Combined)	$2.8M	0.8% ($2.8M/$352.7M)	QoQ +50.30% (+$924.6K) YoY NEW(+$2.8M)
ACCURAY INC(ARAYcusip004397105)	1.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.2M	0.6% ($2.2M/$352.7M)	QoQ -9.59% (-$232.2K) YoY -27.53% (-$831.2K)
2seventy bio, Inc.(TSVTcusip901384107)	429.3K	QoQ 0.00% (+0) YoY -64.34% (-774.8K)	All Managers (Combined)	$2.1M	0.6% ($2.1M/$352.7M)	QoQ +68.02% (+$858.5K) YoY -67.08% (-$4.3M)
ProQR Therapeutics N.V.(PRQRcusipN71542109)	1.6M	QoQ 0.00% (-0) YoY +73.09% (+662.0K)	All Managers (Combined)	$2.1M	0.6% ($2.1M/$352.7M)	QoQ -49.81% (-$2.1M) YoY +0.53% (+$11.2K)
COMPASS Pathways plc(CMPScusip20451W101)	711.0K	QoQ +192.35% (+467.8K) YoY +192.35% (+467.8K)	All Managers (Combined)	$2.0M	0.6% ($2.0M/$352.7M)	QoQ +121.20% (+$1.1M) YoY +0.49% (+$10.1K)
Allogene Therapeutics, Inc.(ALLOcusip019770106)	1.4M	QoQ +11.28% (-140.0K) YoY NEW(+1.4M)	All Managers (Combined)	$2.0M	0.6% ($2.0M/$352.7M)	QoQ -23.71% (-$626.5K) YoY NEW(+$2.0M)
TELA Bio, Inc.(TELAcusip872381108)	1.4M	QoQ 0.00% (-0) YoY NEW(+1.4M)	All Managers (Combined)	$1.8M	0.5% ($1.8M/$352.7M)	QoQ -59.60% (-$2.6M) YoY NEW(+$1.8M)
ALIGN TECHNOLOGY INC(ALGNcusip016255101)	11.0K	QoQ +100.00% (+5.5K) YoY NEW(+11.0K)	All Managers (Combined)	$1.7M	0.5% ($1.7M/$352.7M)	QoQ +52.37% (+$600.7K) YoY NEW(+$1.7M)